Globus Medical (GMED) PT Lowered to $64 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $87.11 +2.34%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Drew Ranieri lowered the price target on Globus Medical (NYSE: GMED) to $64.00 (from $78.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Wyndham Hotels (WH) PT Lowered to $91 at Morgan Stanley
- Nebius Group (NBIS) PT Raised to $250 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
